These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9333056)

  • 1. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.
    Tait-Kamradt A; Clancy J; Cronan M; Dib-Hajj F; Wondrack L; Yuan W; Sutcliffe J
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2251-5. PubMed ID: 9333056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible.
    Ambrose KD; Nisbet R; Stephens DS
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4203-9. PubMed ID: 16189099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics.
    Nishijima T; Saito Y; Aoki A; Toriya M; Toyonaga Y; Fujii R
    J Antimicrob Chemother; 1999 May; 43(5):637-43. PubMed ID: 10382884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.
    Sutcliffe J; Tait-Kamradt A; Wondrack L
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1817-24. PubMed ID: 8843287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.
    Hsueh PR; Teng LJ; Lee LN; Yang PC; Ho SW; Lue HC; Luh KT
    Microb Drug Resist; 2002; 8(1):27-33. PubMed ID: 12002646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
    Descheemaeker P; Chapelle S; Lammens C; Hauchecorne M; Wijdooghe M; Vandamme P; Ieven M; Goossens H
    J Antimicrob Chemother; 2000 Feb; 45(2):167-73. PubMed ID: 10660498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide resistance in Belgian Streptococcus pneumoniae.
    Lagrou K; Peetermans WE; Verhaegen J; Van Lierde S; Verbist L; Van Eldere J
    J Antimicrob Chemother; 2000 Jan; 45(1):119-21. PubMed ID: 10629023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae.
    Johnston NJ; De Azavedo JC; Kellner JD; Low DE
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2425-6. PubMed ID: 9736575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
    Giovanetti E; Montanari MP; Marchetti F; Varaldo PE
    J Antimicrob Chemother; 2000 Dec; 46(6):905-8. PubMed ID: 11102408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
    Ardanuy C; Tubau F; Liñares J; Domínguez MA; Pallarés R; Martín R;
    Antimicrob Agents Chemother; 2005 Feb; 49(2):827-9. PubMed ID: 15673780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.
    Clancy J; Petitpas J; Dib-Hajj F; Yuan W; Cronan M; Kamath AV; Bergeron J; Retsema JA
    Mol Microbiol; 1996 Dec; 22(5):867-79. PubMed ID: 8971709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment.
    Gay K; Baughman W; Miller Y; Jackson D; Whitney CG; Schuchat A; Farley MM; Tenover F; Stephens DS
    J Infect Dis; 2000 Nov; 182(5):1417-24. PubMed ID: 11023465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile.
    Palavecino EL; Riedel I; Duran C; Bajaksouzian S; Joloba M; Davies T; Appelbaum PC; Jacobs MR
    Int J Antimicrob Agents; 2002 Aug; 20(2):108-12. PubMed ID: 12297359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
    Giovanetti E; Montanari MP; Mingoia M; Varaldo PE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1935-40. PubMed ID: 10428916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
    Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
    Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates.
    Klugman KP; Capper T; Widdowson CA; Koornhof HJ; Moser W
    J Antimicrob Chemother; 1998 Dec; 42(6):729-34. PubMed ID: 10052895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae].
    Zhao TM; Liu YN
    Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):329-32. PubMed ID: 15182500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing].
    Yang H; Shen XZ; Wang YH; Yuan L; Yu SJ; Yang YH
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):936-9. PubMed ID: 15733368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.